Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal
NACompletedINTERVENTIONAL
Enrollment
64
Participants
Timeline
Start Date
September 30, 2012
Primary Completion Date
July 31, 2019
Study Completion Date
December 31, 2019
Conditions
Metastatic Anal Canal CancerHuman Papillomavirus
Interventions
DRUG
DCF regimen
Trial Locations (1)
25000
Medical Oncology - University Hospital of Besançon, Besançon
All Listed Sponsors
lead
Centre Hospitalier Universitaire de Besancon
OTHER
NCT01845779 - Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal | Biotech Hunter | Biotech Hunter